AU2020293094A1 - Methods and compositions for altering senescence associated secretory phenotype - Google Patents
Methods and compositions for altering senescence associated secretory phenotype Download PDFInfo
- Publication number
- AU2020293094A1 AU2020293094A1 AU2020293094A AU2020293094A AU2020293094A1 AU 2020293094 A1 AU2020293094 A1 AU 2020293094A1 AU 2020293094 A AU2020293094 A AU 2020293094A AU 2020293094 A AU2020293094 A AU 2020293094A AU 2020293094 A1 AU2020293094 A1 AU 2020293094A1
- Authority
- AU
- Australia
- Prior art keywords
- akg
- composition
- subject
- vitamin
- composition comprises
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/194—Carboxylic acids, e.g. valproic acid having two or more carboxyl groups, e.g. succinic, maleic or phthalic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
- A61K31/07—Retinol compounds, e.g. vitamin A
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/59—Compounds containing 9, 10- seco- cyclopenta[a]hydrophenanthrene ring systems
- A61K31/593—9,10-Secocholestane derivatives, e.g. cholecalciferol, i.e. vitamin D3
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2013—Organic compounds, e.g. phospholipids, fats
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Dermatology (AREA)
- Neurology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Physical Education & Sports Medicine (AREA)
- Inorganic Chemistry (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Biophysics (AREA)
- Molecular Biology (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201962859623P | 2019-06-10 | 2019-06-10 | |
| US62/859,623 | 2019-06-10 | ||
| PCT/US2020/036974 WO2020252005A1 (en) | 2019-06-10 | 2020-06-10 | Methods and compositions for altering senescence associated secretory phenotype |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AU2020293094A1 true AU2020293094A1 (en) | 2022-01-06 |
Family
ID=73781254
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AU2020293094A Abandoned AU2020293094A1 (en) | 2019-06-10 | 2020-06-10 | Methods and compositions for altering senescence associated secretory phenotype |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US20220241229A1 (cg-RX-API-DMAC7.html) |
| EP (1) | EP3980000A4 (cg-RX-API-DMAC7.html) |
| JP (1) | JP2022536653A (cg-RX-API-DMAC7.html) |
| CN (1) | CN114126599A (cg-RX-API-DMAC7.html) |
| AU (1) | AU2020293094A1 (cg-RX-API-DMAC7.html) |
| CA (1) | CA3142781A1 (cg-RX-API-DMAC7.html) |
| WO (1) | WO2020252005A1 (cg-RX-API-DMAC7.html) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN112955139B (zh) | 2018-09-25 | 2025-04-18 | 庞塞迪利昂健康特定活动公司 | 用于制备α-酮戊二酸钙的方法 |
| DE102021111719A1 (de) * | 2021-05-05 | 2022-11-10 | Henkel Ag & Co. Kgaa | Erhalt der Haarstruktur gegenüber Umwelteinflüssen umfassend ein Phenol und multivalente Ionen |
| WO2023191106A1 (ja) * | 2022-04-01 | 2023-10-05 | 公益財団法人がん研究会 | 老化細胞もしくはsaspを標的とした治療薬/予防薬、老化細胞を検出するデータの取得方法及び治療薬/予防薬のスクリーニング方法 |
| EP4561696A4 (en) * | 2022-06-30 | 2026-07-15 | Mechanobiologics Inc | REVERSAL OF CELLULAR SENENCE BY LOW-FREQUENCY ULTRASOUND TREATMENT |
| CN115813784A (zh) * | 2022-11-28 | 2023-03-21 | 麦吉丽生物科技有限公司 | α-酮戊二酸、含有α-酮戊二酸的米发酵液在制备皮肤炎症抑制剂中的用途 |
| WO2024123738A1 (en) * | 2022-12-06 | 2024-06-13 | Ponce De Leon Health Designated Activity Company | Compositions and methods for treating diseases responsive to akg-vitamin b coadministration |
Family Cites Families (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5198465A (en) * | 1991-06-19 | 1993-03-30 | Dioguardi Francesco S | Compositions based on amino acids for preventing and treating precursor deficiencies in the synthesis of collagen |
| CA2447357A1 (en) * | 2001-05-22 | 2002-11-28 | Gene Logic, Inc. | Molecular toxicology modeling |
| ES2510690T3 (es) * | 2004-12-17 | 2014-10-21 | Alan B. Cash | Método para extender la esperanza de vida y retrasar la aparición de enfermedad relacionada con la edad |
| US20070105942A1 (en) * | 2005-11-08 | 2007-05-10 | Heuer Marvin A | Supplemental dietary composition for turning on anabolic switches in muscle, stimulating and/or optimizing protein synthesis, and/or potently signaling muscle building and/or growth via molecular pathways |
| PL379512A1 (pl) * | 2006-04-21 | 2007-10-29 | Sgp & Sons Ab | Nowe metody i ich zastosowanie |
| US20110039935A1 (en) * | 2007-07-02 | 2011-02-17 | Entress Ab | Use of pharmacologically active chemical compounds |
| DE102009016119A1 (de) * | 2009-04-03 | 2010-10-14 | Evonik Degussa Gmbh | Nahrungsergänzungsmittel enthaltend alpha-Ketosäuren zur Unterstützung der Diabetestherapie |
| JP2014512372A (ja) * | 2011-04-18 | 2014-05-22 | ネステク ソシエテ アノニム | α−HICA及びエイコサペンタエン酸を含有する栄養組成物 |
| WO2014116985A1 (en) * | 2013-01-25 | 2014-07-31 | Winning The Fight Inc. | Composition for treatment of neurodegenerative disease |
| US9993472B2 (en) * | 2014-01-28 | 2018-06-12 | Unity Biotechnology, Inc. | Treatment for osteoarthritis in a joint by administering a means for inhibiting MDM2 |
| CN113082009A (zh) * | 2014-02-12 | 2021-07-09 | 加利福尼亚大学董事会 | 用于治疗衰老和与年龄相关的疾病和症状的组合物和方法 |
| CN106963749A (zh) * | 2017-03-23 | 2017-07-21 | 华南农业大学 | α‑酮戊二酸(盐)在抗疲劳和提高肌肉运动力量方面的应用 |
| CA3061381A1 (en) * | 2017-04-25 | 2018-11-01 | Buck Institute For Research On Aging | COMPOSITIONS COMPRISING α-KETOGLUTARATE FOR EXTENDING LIFESPAN AND HEALTHSPAN |
| CN108774203A (zh) * | 2018-06-25 | 2018-11-09 | 北京未蓝时代科技有限公司 | 一种延缓哺乳动物细胞和机体衰老的化合物及其应用 |
| US20210369750A1 (en) * | 2018-10-24 | 2021-12-02 | Ponce De Leon Health Designated Activity Company | Nicotinamide riboside compositions for healthspan extension |
-
2020
- 2020-06-10 CN CN202080052117.8A patent/CN114126599A/zh active Pending
- 2020-06-10 US US17/617,436 patent/US20220241229A1/en not_active Abandoned
- 2020-06-10 JP JP2021573215A patent/JP2022536653A/ja active Pending
- 2020-06-10 CA CA3142781A patent/CA3142781A1/en active Pending
- 2020-06-10 EP EP20823672.9A patent/EP3980000A4/en not_active Withdrawn
- 2020-06-10 AU AU2020293094A patent/AU2020293094A1/en not_active Abandoned
- 2020-06-10 WO PCT/US2020/036974 patent/WO2020252005A1/en not_active Ceased
Also Published As
| Publication number | Publication date |
|---|---|
| US20220241229A1 (en) | 2022-08-04 |
| JP2022536653A (ja) | 2022-08-18 |
| EP3980000A1 (en) | 2022-04-13 |
| WO2020252005A1 (en) | 2020-12-17 |
| CN114126599A (zh) | 2022-03-01 |
| CA3142781A1 (en) | 2020-12-17 |
| EP3980000A4 (en) | 2023-06-21 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US12220424B2 (en) | Compositions comprising nicotinamide riboside and a urolithin | |
| US20220241229A1 (en) | Methods and Compositions for Altering Senescence Associated Secretory Phenotype | |
| US11219590B2 (en) | Anti-aging agent and anti-aging method | |
| JP7745338B2 (ja) | 寿命および健康寿命を延ばすための製剤 | |
| JP2009502958A (ja) | ストレスの治療または管理の方法 | |
| JP2022504771A (ja) | 健康寿命延長を目的とするニコチンアミドリボシド組成物 | |
| KR101842948B1 (ko) | 데칸알 또는 이의 약학적으로 허용 가능한 염을 유효성분으로 포함하는 근육 질환 예방 또는 치료용 조성물 | |
| JP7633238B2 (ja) | ニコチンアミドアデニンジヌクレオチド(nad)濃度上昇剤 | |
| WO2021205975A1 (ja) | 細胞老化抑制用組成物及び細胞老化を抑制する方法 | |
| EP3897617A1 (en) | Novel polymethoxyflavone compounds for skeletal muscle modulation, methods and uses thereof | |
| JP7478895B1 (ja) | 痒みの予防又は改善剤 | |
| US11576875B2 (en) | Composition comprising ethyl vanillin as effective ingredient for exhibiting effect of muscle strengthening, muscle enhancement, muscle differentiation, muscle regeneration, or sarcopenia suppression | |
| JP7271016B2 (ja) | 骨損失疾患の予防、改善または治療のためのchp(シクロ-ヒスプロ)および副甲状腺ホルモンを含む組成物の用途 | |
| HK40071633A (en) | Methods and compositions for altering senescence associated secretory phenotype | |
| JPWO2008136173A1 (ja) | スチルベン誘導体を有効成分とする脂肪細胞分化抑制剤 | |
| JP7829916B2 (ja) | Grem2発現抑制剤 | |
| JP2008543903A (ja) | 非自己免疫性2型糖尿病および/またはx症候群の処置のための化合物 | |
| JP2003511097A (ja) | 栄養補助剤 | |
| WO2024123738A1 (en) | Compositions and methods for treating diseases responsive to akg-vitamin b coadministration | |
| HK40089161A (en) | Nicotinamide adenine dinucleotide (nad) concentration increasing agent | |
| WO2024117172A1 (ja) | 痒みの予防又は改善剤 | |
| JP2024079052A (ja) | 痒みの予防又は改善剤 | |
| JP2018203678A (ja) | 血糖上昇抑制用組成物 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| MK4 | Application lapsed section 142(2)(d) - no continuation fee paid for the application |